In October, the MHRA reviewed data from the earliest trials of Seroxat. The information was supplied by GlaxoSmithKline in the late Eighties, and it was the MHRA's responsibility to analyse the ...

The GlaxoSmithKline website was also searched for relevant studies on paroxetine. Outcome measures were the Clinical Global Impressions scale, the Children's Depression Rating Scale-Revised ...

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy ...

MPs also heard British pharmaceutical company GSK (GlaxoSmithKline) had held back test results that linked the antidepressant paroxetine to an increased risk of child suicide. Similarly ...

The debate was told that GSK (GlaxoSmithKline) had kept back tests which showed that the antidepressant paroxetine increased the chance of children committing suicide. Likewise, in 2010 ...

MPs also heard British pharmaceutical company GSK (GlaxoSmithKline) had held back test results that linked the antidepressant paroxetine to an increased risk of child suicide. Similarly ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...

If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...